Home
> Thomas Kensler

Thomas Kensler

Thomas Kensler

BiomedExperts Profile

Help us refine your profile

Profile

Trends

Research Network

Publications

1.
2013

Dionysios V Chartoumpekis; Thomas W Kensler

New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome.
Current diabetes reviews 2013;9(2):137-45.
2.
2013

Navneet Ammal Kaidery; Rebecca Banerjee; Lichuan Yang; Natalya A Smirnova; Dmitry M Hushpulian; Karen T Liby; Charlotte R Williams; Masayuki Yamamoto; Thomas W Kensler; Rajiv R Ratan; et al.

Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.
Antioxidants & redox signaling 2013;18(2):139-57.
3.
2013

Thomas W Kensler; Patricia A Egner; Abena S Agyeman; Kala Visvanathan; John D Groopman; Jian-Guo Chen; Tao-Yang Chen; Jed W Fahey; Paul Talalay

Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane.
Topics in current chemistry 2013;329():163-77.

Similar Experts

Journals

Publications
Carcinogenesis

34
Cancer research

25
Chemical research in...

20
Journal of medicinal...

11
Proceedings of the N...

11

Coauthor Network

Internal Coauthors

Shared Pub.
John Groopman

74
Patricia Egner

47
Patrick Dolan

37
Shyam Biswal

23
Michael Trush

19
Alvaro Munoz

18

External Coauthors

Shared Pub.
Masayuki Yamamoto

38
Bill D Roebuck

32
Gary H Posner

25
Thomas R Sutter

20
Mi-Kyoung Kwak

19
Geng-Sun Qian

18